#1 Ranked Children’s Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
There are many ways you can help children and their families get the care they need.
A pilocytic astrocytoma is a brain tumor that originates from star-shaped cells called astrocytes. Astrocytes are a kind of glial cell, cells that support and nourish neurons in the brain. An astrocytoma is a type of glioma, and pilocytic astrocytomas are low-grade gliomas—a family of slow-growing tumors that arise from glial cells. They are the most benign and most treatable of the gliomas, with a cure rate of over over 90 percent.
Children with pilocytic astrocytomas are treated at Dana-Farber/Boston Children's through our Brain Tumor Center's Glioma Program, one of the largest and most experienced pediatric glioma programs in the world. Our glioma specialists—a team of neuro-oncologists, surgeons, pathologists and radiation oncologists—focus solely on the care of children diagnosed with gliomas.
Find in-depth information on pilocytic astroctyomas on the Dana-Farber/Boston Children's website, including answers to:
We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”